Sana Biotechnology Inc
Research Sana Biotechnology Inc (SANA) on Bullrun: market cap USD 1.23B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSANA
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.23B
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 241.99M
- Free cash flow-USD 133.64M
Valuation Snapshot
latest market cap is USD 1.23B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 244.17M | -USD 144.77M | n/a | -0.96 | USD 71.87M | USD 78.86M | USD 160.88M |
| FY2024 | USD 0 | -USD 266.76M | -USD 256.58M | n/a | -1.16 | USD 127.57M | USD 94.20M | USD 250.50M |
| FY2023 | USD 0 | -USD 283.26M | -USD 273.61M | n/a | -1.46 | USD 133.52M | USD 104.10M | USD 287.51M |
| FY2022 | n/a | -USD 269.48M | -USD 310.93M | n/a | -1.43 | USD 176.77M | USD 113.63M | USD 499.32M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.23B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.09B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 364.99M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 804.30M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 753.37M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 2.86B | n/a | n/a | n/a |
About Sana Biotechnology Inc
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sana Biotechnology Inc's market cap?
Sana Biotechnology Inc's market capitalization is USD 1.23B.
What does Sana Biotechnology Inc do?
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology.